Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1158 Articles

Chris Lange | Sep 17, 2015 at 9:55 AM EDT

Achillion Pharma Rises on Solid Interim Results

Its stock has suffered, but it is possible that Achillion’s interim trial results may have put the company back on…

Paul Ausick | Sep 3, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the DJIA Thursday

thinkstockSeptember 3, 2015: Markets opened higher on Thursday after the European Central Bank president indicated that the ECB would continue quantitative…

Paul Ausick | Aug 28, 2015 at 4:01 PM EDT

The 4 Stocks That Held Down the DJIA on Friday

thinkstockAugust 28, 2015: Markets opened lower on Friday, and except for a brief visit above the break-even line, the blue…

Paul Ausick | Aug 24, 2015 at 1:35 PM EDT

Dow Stocks Recover 90% of Opening Loss

Led by Apple and Intel, the Dow 30 stocks have engineered a significant recovery since the opening bell rang Monday…

Lee Jackson | Aug 24, 2015 at 8:10 AM EDT

4 Defensive Stocks to Buy for Continued Market Volatility

In a new research report, the technical team at RBC highlight stocks and sectors that are working and are clearly…

Douglas A. McIntyre | Aug 24, 2015 at 6:29 AM EDT

Where Will Warren Buffett Put Money as Markets Collapse?

Where will the most brilliant investor in the world put his money if the markets collapse? Perhaps into some of…

Jon C. Ogg | Aug 10, 2015 at 3:19 PM EDT

Why AbbVie Should Be Worth 25% More

Independent research firm Argus has maintained its Buy rating and its $85.00 price target on AbbVie.

Douglas A. McIntyre | Aug 2, 2015 at 8:00 AM EDT

5 Dividend Stocks for Your Portfolio

Stockcharts.comLong-term investors always look for companies that show signs that they will be around for a while. Membership on the…

Paul Ausick | Jul 17, 2015 at 4:01 PM EDT

The 4 Stocks That Sank the DJIA on Friday

July 17, 2thinkstock015: Markets opened mixed on Friday as the Nasdaq traded higher right from the opening bell and the…

Lee Jackson | Jul 16, 2015 at 9:35 AM EDT

UBS Makes Summer Changes to Dividend Ruler Stocks Portfolio

A new report from UBS includes changes to the firm's Dividend Ruler stocks portfolio. Also featured are the current four…

Chris Lange | Jul 14, 2015 at 8:40 AM EDT

Johnson & Johnson Posts Q2 Earnings Beat

Johnson & Johnson reported better-than-expected second-quarter financial results before the markets opened Tuesday.

Chris Lange | Jul 13, 2015 at 11:10 AM EDT

What to Expect From Johnson & Johnson Earnings

Johnson & Johnson is expected to report its second-quarter financial results Tuesday morning before the markets open.

Chris Lange | Jul 12, 2015 at 9:10 AM EDT

6 Key DJIA Earnings for the Week Ahead

Earnings season for the second quarter of the calendar year has kicked off, and 24/7 Wall St. has put together…

Lee Jackson | Jul 7, 2015 at 10:20 AM EDT

UBS Makes Changes to Dividend Ruler Stock List

With the Greek debacle throwing some very cold water on the market, it makes sense for investors to use cash…

Chris Lange | Jul 7, 2015 at 7:35 AM EDT

5 Big Upcoming FDA Decisions Expected in July

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of July and…

1 … 39 40 41 42 43 … 78

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Achillion Pharma Rises on Solid Interim Results

The 4 Stocks That Weighed on the DJIA Thursday

The 4 Stocks That Held Down the DJIA on Friday

Dow Stocks Recover 90% of Opening Loss

4 Defensive Stocks to Buy for Continued Market Volatility

Where Will Warren Buffett Put Money as Markets Collapse?

Why AbbVie Should Be Worth 25% More

5 Dividend Stocks for Your Portfolio

The 4 Stocks That Sank the DJIA on Friday

UBS Makes Summer Changes to Dividend Ruler Stocks Portfolio

Johnson & Johnson Posts Q2 Earnings Beat

What to Expect From Johnson & Johnson Earnings

6 Key DJIA Earnings for the Week Ahead

UBS Makes Changes to Dividend Ruler Stock List

5 Big Upcoming FDA Decisions Expected in July

NVDL Collapsed 12% in a Single Day as Nvidia Lost $279 Billion, Exposing How Leverage Compounds on Bad Tape

Exxon Got Kicked Out of the Dow in 2020. It Has Since Beaten the S&P 500 by Nearly Double

NUGT Collapsed 17% on Friday While Gold Fell Just 3%: The Hidden Leverage Destroying Miners ETF Holders

69-Year-Old Widow With $890,000 in Late Husband's IRA Faces a Massive Tax Bill if She Isn't Careful

The Six-Month Medicare Lookback That Costs a 66-Year-Old HSA Holder $7,800 in Excess Contributions Penalties She Didn't See Coming

NVDL Collapsed 12% in a Single Day as Nvidia Lost $279 Billion, Exposing How Leverage Compounds on Bad Tape

Exxon Got Kicked Out of the Dow in 2020. It Has Since Beaten the S&P 500 by Nearly Double

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Achillion Pharma Rises on Solid Interim Results

The 4 Stocks That Weighed on the DJIA Thursday

The 4 Stocks That Held Down the DJIA on Friday

Dow Stocks Recover 90% of Opening Loss

4 Defensive Stocks to Buy for Continued Market Volatility

Where Will Warren Buffett Put Money as Markets Collapse?

Why AbbVie Should Be Worth 25% More

5 Dividend Stocks for Your Portfolio

The 4 Stocks That Sank the DJIA on Friday

UBS Makes Summer Changes to Dividend Ruler Stocks Portfolio

Johnson & Johnson Posts Q2 Earnings Beat

What to Expect From Johnson & Johnson Earnings

6 Key DJIA Earnings for the Week Ahead

UBS Makes Changes to Dividend Ruler Stock List

5 Big Upcoming FDA Decisions Expected in July

NVDL Collapsed 12% in a Single Day as Nvidia Lost $279 Billion, Exposing How Leverage Compounds on Bad Tape

Exxon Got Kicked Out of the Dow in 2020. It Has Since Beaten the S&P 500 by Nearly Double

NUGT Collapsed 17% on Friday While Gold Fell Just 3%: The Hidden Leverage Destroying Miners ETF Holders

Featured Reads

69-Year-Old Widow With $890,000 in Late Husband's IRA Faces a Massive Tax Bill if She Isn't Careful

The Six-Month Medicare Lookback That Costs a 66-Year-Old HSA Holder $7,800 in Excess Contributions Penalties She Didn't See Coming